BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2453758)

  • 1. Generation of mature CD3+ and T cell receptor (TCR) + T cells from a leukemic analogue of the putative human stem cell by T cell conditioned medium containing IL-3, IL-2, and GM-CSF.
    Schneider EM; Lorenz I; Leippold S; Zischler H; Clark SC; Wernet P
    Leukemia; 1988 May; 2(5):282-9. PubMed ID: 2453758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of an undifferentiated human T leukemia cell line which requires granulocyte-macrophage colony stimulatory factor for growth.
    Valtieri M; Santoli D; Caracciolo D; Kreider BL; Altmann SW; Tweardy DJ; Gemperlein I; Mavilio F; Lange B; Rovera G
    J Immunol; 1987 Jun; 138(11):4042-50. PubMed ID: 2953797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mature T-lineage leukemia with growth factor-induced multilineage differentiation.
    Griesinger F; Arthur DC; Brunning R; Parkin JL; Ochoa AC; Miller WJ; Wilkowski CW; Greenberg JM; Hurvitz C; Kersey JH
    J Exp Med; 1989 Mar; 169(3):1101-20. PubMed ID: 2538542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
    Gazzola MV; Collins NH; Tafuri A; Keever CA
    Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction.
    Kelso A
    J Immunol; 1990 Oct; 145(7):2167-76. PubMed ID: 1975827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of IL-2-driven T cell proliferation by recombinant human IL-3 and granulocyte-macrophage colony-stimulating factor.
    Santoli D; Clark SC; Kreider BL; Maslin PA; Rovera G
    J Immunol; 1988 Jul; 141(2):519-26. PubMed ID: 3290340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
    Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation in DNA synthesis by colony-stimulating factors in subsets of human CD34+ marrow cells.
    Strauss LC; Welsh SB; Civin CI
    Exp Hematol; 1991 Sep; 19(8):734-41. PubMed ID: 1714400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor-dependent differentiation along the myeloid and lymphoid lineages in an immature acute T lymphocytic leukemia.
    O'Connor R; Cesano A; Kreider BL; Lange B; Clark SC; Nowell PC; Finan J; Rovera G; Santoli D
    J Immunol; 1990 Dec; 145(11):3779-87. PubMed ID: 2246514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
    Santoli D; Yang YC; Clark SC; Kreider BL; Caracciolo D; Rovera G
    J Immunol; 1987 Nov; 139(10):3348-54. PubMed ID: 3500218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome.
    Schrezenmeier H; Thomé SD; Tewald F; Fleischer B; Raghavachar A
    Exp Hematol; 1993 Feb; 21(2):358-65. PubMed ID: 8425573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
    Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
    Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous IL-7 promotes the growth of CD3-CD4-CD8-CD44+CD25+/- precursor cells and blocks the differentiation pathway of TCR-alpha beta cells in fetal thymus organ culture.
    Plum J; De Smedt M; Leclercq G
    J Immunol; 1993 Apr; 150(7):2706-16. PubMed ID: 8095954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-kit ligand combined with GM-CSF and/or IL-3 can expand CD34+ hematopoietic progenitor subsets for several weeks in vitro.
    Steen R; Mørkrid L; Tjønnfjord GE; Egeland T
    Stem Cells; 1994 Mar; 12(2):214-24. PubMed ID: 7515297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine-producing cell-stimulating activity. A biological activity shared by interleukin 3 and granulocyte-macrophage colony-stimulating factor.
    Dy M; Schneider E; Gastinel LN; Auffray C; Mermod JJ; Hamburger J
    Eur J Immunol; 1987 Sep; 17(9):1243-8. PubMed ID: 2888659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension culture.
    Miyauchi J; Kelleher CA; Wong GG; Yang YC; Clark SC; Minkin S; Minden MD; McCulloch EA
    Leukemia; 1988 Jun; 2(6):382-7. PubMed ID: 2453760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
    Uckun FM; Myers DE; Ledbetter JA; Swaim SE; Gajl-Peczalska KJ; Vallera DA
    J Immunol; 1988 Mar; 140(6):2103-11. PubMed ID: 3126241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.